GenapSys Gets Court OK For $42M Sale To Investor Group
Law 360 M&A
SEPTEMBER 8, 2022
Gene-sequencing company GenapSys Inc. won a bankruptcy court's approval Thursday to sell its assets to an investor group for $42 million despite a last-minute plea from Bolt Financial Inc.'s s CEO Ryan Breslow to postpone the sale so his new pharma startup could put in a competing bid.
40 
Let's personalize your content